TspanCure

Tackling cancer heterogeneity

Institution:

Research Group:

Biomedical Research in Cancer Stem Cells

Researcher/s:

Dr. Matilde E. LLeonart, Dr. Gerard Pujadas, Dr. Amadeu Llebaria

The technology
Media

Description:

Tackling cancer heterogeneity: a breakthrough in overcoming chemoresistant tumors First-in-class drugs against a new therapeutic target whose overexpression is involved in the malignancy of very specific cancer types, including HNSCC, pancreatic, breast, among others.

Value Proposition:

A new family of molecules against a novel therapeutic target which is overexpressed in HNSCC and related with the resistance acquisition developed by HNSCC patients after chemotherapy.

Aplication areas:

Health

Target market:

Big companies and start-ups developing treatments against HNSCC.

Technology Readiness Level (1-9): 3

More information

if you want to know more about this project do not hesitate to contact us